LY-3023414 Active Not Recruiting Phase 2 Trials for Metastatic Hormone Refractory Prostate Cancer Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02407054A Study of Enzalutamide and LY3023414 in Men With Prostate Cancer